Mehdi M Moezi MD FACP
Breast Cancer, Gastrointestinal Cancer, Hematologic Oncology, Thoracic Cancer
Cancer Specialists of North Florida
Join to view full profile
2370 Market DrFleming Island, FL 32003
Phone+1 904-363-2113
Fax+1 904-264-6858
Dr. Moezi is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
SUNY Downstate Health Sciences UniversityFellowship, Hematology and Medical Oncology, 1998 - 2001
One Brooklyn Health System/Interfaith Medical CenterResidency, Internal Medicine, 1995 - 1998
Tehran University of Medical Sciences School of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 2005 - Present
FL State Medical License 2000 - 2028
UT State Medical License 1998 - 2006
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Clinical Trials
- Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
- Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant Start of enrollment: 2011 Apr 20
- Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma Start of enrollment: 2011 Aug 04
Publications & Presentations
PubMed
- Impact of Comorbidities on Clinical Outcomes and Quality of Life of Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2...Debu Tripathy, Joanne L Blum, Meghan S Karuturi, Steven McCune, Sobha Kurian
Cancer Medicine. 2026-04-01 - 8 citationsReal-world effectiveness of palbociclib plus endocrine therapy in HR+/HER2- advanced breast cancer: final results from the POLARIS trial.Debu Tripathy, Joanne L Blum, Meghan S Karuturi, Steven McCune, Sobha Kurian
The Oncologist. 2025-07-04 - A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and Methylprednisolone.James R Berenson, Andrea Limon, Stephanie Rice, Tahmineh Safaie, Ralph Boccia
Targeted Oncology. 2024-05-01
Professional Memberships
- Member
- Member
- Member
- Member
- European Society of Medical OncologyMember
Other Languages
- Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
